{"id": "1356324805029588994", "creation": 1612208007.0, "user_id": "1233901069366771712", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 2, "quote_count": 0}}, "text": "$NVAX Reports 89% #COVID19 Vaccine Efficacy - 150M Doses/Month Production Capacity\n\n$PFE $MRNA &amp; $AZN have all experienced manufacturing shortfalls in ramping up #vaccine production so we can treat the CEO's claim lightly\n\n$JNJ #StocksToWatch #trading\n\nhttps://t.co/Fr0aJQtUyg", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#STOCKSTOWATCH", "#TRADING"]}